UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056460
Receipt number R000064456
Scientific Title A single-arm feasibility study to examine the effects of ICT-based social prescribing with wellbeing coordinators on improving wellbeing in isolated older adults
Date of disclosure of the study information 2024/12/15
Last modified on 2024/12/14 21:12:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-arm feasibility study to examine the effects of ICT-based social prescribing with wellbeing coordinators on improving wellbeing in isolated older adults

Acronym

A single-arm feasibility study to examine the effects of ICT-based social prescribing with wellbeing coordinators on improving wellbeing in isolated older adults

Scientific Title

A single-arm feasibility study to examine the effects of ICT-based social prescribing with wellbeing coordinators on improving wellbeing in isolated older adults

Scientific Title:Acronym

A single-arm feasibility study to examine the effects of ICT-based social prescribing with wellbeing coordinators on improving wellbeing in isolated older adults

Region

Japan


Condition

Condition

Hypertension, Dyslipidemia, Type 2 Diabetes Mellitus, Chronic Kidney Disease, Ischemic Heart Disease, and other Internal Medicine Conditions,As well as orthopedic diseases such as knee osteoarthritis and low back pain.

Classification by specialty

Medicine in general Geriatrics Orthopedics
Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To collect preliminary information for planning a study protocol and sample size calculation, and to assess the feasibility of a large-scale study, which will examine the effects of ICT-based social prescribing with well-being coordinators on improving the well-being of socially isolated older adults.

Basic objectives2

Others

Basic objectives -Others

Feasibility study

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Items related to the feasibility of a large-scale study: recruitment success rate, data collection compliance, acceptability of intervention methods, success rate of link workers in facilitating activities, and rate of obtaining blood test results.

Key secondary outcomes

Indicators necessary to assess the effectiveness and safety of the intervention: subjective well-being, physical activity levels, degree of frailty, degree of social isolation, general blood test values, facilitated community activities, satisfaction with ICT tools, adverse events, etc.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Social describing for 6 months with standard treatment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Aged 65 years or older.
2) Individuals meeting any of the following criteria for social isolation:
(a) Less than one contact per week with a person other than cohabitants.
(b) Living alone.
(c) Any other case where a physician deems the individual to be at high risk of social isolation.
3) Individuals with chronic diseases: internal diseases such as hypertension, dyslipidemia, type 2 diabetes, chronic kidney disease, ischemic heart disease, as well as orthopedic diseases such as knee osteoarthritis and low back pain.
4) Individuals who own a smartphone.

Key exclusion criteria

1) Individuals deemed to have communication difficulties due to cognitive impairment or hearing loss.
2) Any other individual whom the principal investigator deems unsuitable for participation in the study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shinji
Middle name
Last name Sato

Organization

Teikyo University

Division name

Faculty of Medical Technology

Zip code

192-0395

Address

359, Otsuka, Hachioji-shi, Tokyo

TEL

0120-508-739

Email

shinjisato2005hawaii@yahoo.co.jp


Public contact

Name of contact person

1st name Shinji
Middle name
Last name Sato

Organization

Teikyo University

Division name

Faculty of Medical Technology

Zip code

192-0395

Address

359, Otsuka, Hachioji-shi, Tokyo

TEL

0120-508-739

Homepage URL


Email

shinjisato2005hawaii@yahoo.co.jp


Sponsor or person

Institute

Teikyo University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teikyo university Integrated Research Ethics Board

Address

2-11-1, Kaga, Itabashi-ku, Tokyo

Tel

03-3964-1211

Email

turb-office@teikyo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 12 Month 04 Day

Date of IRB

2024 Year 12 Month 04 Day

Anticipated trial start date

2024 Year 12 Month 04 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 12 Month 14 Day

Last modified on

2024 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064456